Table of Contents
From the Editor
- It’s an exciting timeto be a rheumatologist
I recall giving patients gold shots. Now we have therapies that are truly golden.
Medical Grand Rounds
- Listen to the sounds of life
My near-death experience taught me to be thankful for the sounds we can hear and treasure.
Current Drug Therapy
- Update in ARDS management: Recent randomized controlled trials that changed our practice
Although the death rate remains high in the acute respiratory distress syndrome (ARDS), several advances have been made in the past decade.
The Clinical Picture
- The yin and yang of tumor necrosis factor inhibitors
The most potent and effective therapies sometimes have the most dangerous side effects.
Im Board Review
- Aldosterone receptor antagonists for heart failure: Current status, future indications
Many patients with heart failure should receive one of these drugs. We review the evidence and indications.
Review
- A middle-aged man with progressive neurologic deficits and bilateral leg lesions
His speech is severely impaired and he cannot swallow liquids or solids. The leg lesions have been present for several years and are painless. What is the likely diagnosis?
Editorial
- A young man with a cough, an abnormal chest radiograph, and multiple skin lesions
His chest infiltrates have not resolved after 1 month of illness and two antibiotic courses. What is the diagnosis?
Departments
- Buying prescription drugs on the Internet: Promises and pitfalls
Patients can save time and money, but they can also end up with counterfeit or substandard medications.
Anemia in chronic kidney disease: Causes, diagnosis, treatmentMost patients with chronic kidney disease eventually become anemic and need erythropoiesis-stimulating agents.
- Should all patientswith chronic kidney disease receive an EPO-type drug?
Many patients either do not receive these drugs or have low hemoglobin levels despite treatment. Thus, there are opportunities for better management.
Commentary